AAAAAA
Results:
1-11
|
Results: 11
Authors:
Slooter, AJC
Bots, ML
Havekes, LM
del Sol, AI
Cruts, M
Grobbee, DE
Hofman, A
Van Broeckhoven, C
Witteman, JCM
van Duijn, CM
Citation: Ajc. Slooter et al., Apolipoprotein E and carotid artery atherosclerosis - The Rotterdam study, STROKE, 32(9), 2001, pp. 1947-1952
Authors:
Roks, G
Cruts, M
Slooter, AJC
Dermaut, B
Hofman, A
Van Broeckhoven, C
Van Duijn, CM
Citation: G. Roks et al., The cystatin C polymorphism is not associated with early onset Alzheimer'sdisease, NEUROLOGY, 57(2), 2001, pp. 366-367
Authors:
Slooter, AJC
Cruts, M
Hofman, A
van Duijin, CM
Citation: Ajc. Slooter et al., Apolipoprotein E and longevity: The Rotterdam study, J AM GER SO, 49(9), 2001, pp. 1258-1259
Authors:
Slooter, AJC
Ruitenberg, A
van Duijn, CM
Breteler, MMB
Citation: Ajc. Slooter et al., The effect of apoE on dementia is not through atherosclerosis: The Rotterdam Study - Reply, NEUROLOGY, 54(12), 2000, pp. 2357-2358
Authors:
Slooter, AJC
Houwing-Duistermaat, JJ
van Harskamp, F
Cruts, M
Van Broeckhoven, C
Breteler, MMB
Hofman, A
Stijnen, T
van Duijn, CM
Citation: Ajc. Slooter et al., Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam study, J NEUROL, 246(4), 1999, pp. 304-308
Authors:
Tol, J
Roks, G
Slooter, AJC
van Duijn, CM
Citation: J. Tol et al., Genetic and environmental factors in Alzheimer's disease, REV NEUROL, 155, 1999, pp. 4S10-4S16
Authors:
Mehta, KM
Ott, A
Kalmijn, S
Slooter, AJC
van Duijn, CM
Hofman, A
Breteler, MMB
Citation: Km. Mehta et al., Head trauma and risk of dementia and Alzheimer's disease - The Rotterdam Study, NEUROLOGY, 53(9), 1999, pp. 1959-1962
Authors:
Slooter, AJC
Cruts, M
Ott, A
Bots, ML
Witteman, JCM
Hofman, A
Van Broeckhoven, C
Breteler, MMB
van Duijn, CM
Citation: Ajc. Slooter et al., The effect of APOE on dementia is not through atherosclerosis: The Rotterdam Study, NEUROLOGY, 53(7), 1999, pp. 1593-1595
Authors:
Slooter, AJC
Bronzova, J
Witteman, JCM
Van Broeckhoven, C
Hofman, A
van Duijn, CM
Citation: Ajc. Slooter et al., Estrogen use and early onset Alzheimer's disease: a population-based study, J NE NE PSY, 67(6), 1999, pp. 779-781
Authors:
Dermaut, B
Cruts, M
Slooter, AJC
Van Gestel, S
De Jonghe, C
Vanderstichele, H
Vanmechelen, E
Breteler, MM
Hofman, A
van Duijn, CM
Van Broeckhoven, C
Citation: B. Dermaut et al., The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease, AM J HU GEN, 64(1), 1999, pp. 290-292
Authors:
Dermaut, B
Cruts, M
Slooter, AJC
Van Gestel, S
De Jonghe, C
Backhovens, H
Vanderstichele, H
Vanmechelen, E
Breteler, MMB
Hofman, A
Hendriks, L
Van Duijn, CM
Van Broeckhoven, C
Citation: B. Dermaut et al., Glu318Gly in presenilin-1 is a neutral mutation in relation to dementia: The Rotterdam study, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 87-92
Risultati:
1-11
|